Cancer cachexia
- 28 May 2004
- journal article
- review article
- Published by Springer Nature in Langenbecks Archives Of Surgery
- Vol. 389 (4) , 299-305
- https://doi.org/10.1007/s00423-004-0486-7
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factorBritish Journal of Surgery, 2000
- Prognosis of advanced pancreatic cancer patients with reference to calorie intakeNutrition and Cancer, 1998
- Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patientsSupportive Care in Cancer, 1997
- Is there a role for melatonin in the treatment of neoplastic cachexia?European Journal Of Cancer, 1996
- The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: A randomised double-blind placebo controlled trialEuropean Journal Of Cancer, 1993
- Tumor necrosis factor, cytokines, and the hyperlipidemia of infectionTrends in Endocrinology & Metabolism, 1991
- A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexiaCancer, 1990
- Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.Journal of Clinical Investigation, 1988
- The yeast DNA repair gene RAD6 encodes a ubiquitin-conjugating enzymeNature, 1987
- Stimulation of Muscle Protein Degradation and Prostaglandin E2Release by Leukocytic Pyrogen (Interleukin-1)New England Journal of Medicine, 1983